Searching for pathogenic gene functions to cervical cancer
- 30 April 2004
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 93 (1) , 41-48
- https://doi.org/10.1016/j.ygyno.2003.11.031
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- PCR based high risk HPV testing is superior to neural network based screening for predicting incident CIN III in women with normal cytology and borderline changesJournal of Clinical Pathology, 2000
- HPV-18 E6*I protein modulates the E6-directed degradation of p53 by binding to full-length HPV-18 E6Oncogene, 1999
- Absence of papillomavirus DNA in normal tissue adjacent to most cervical intraepithelial neoplasmsPublished by Wolters Kluwer Health ,1999
- Radiation-enhanced expression of E6/E7 transforming oncogenes of human papillomavirus-16 in human cervical carcinomaCancer, 1998
- Human papillomavirus 16 and 18 infection of the uterine cervix in women with different grades of cervical intraepithelial neoplasia (CIN)International Journal of Gynecology & Obstetrics, 1998
- p53, the Cellular Gatekeeper for Growth and DivisionCell, 1997
- Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage.Proceedings of the National Academy of Sciences, 1993
- The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines.Proceedings of the National Academy of Sciences, 1991
- The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53Published by Elsevier ,1990
- Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53Science, 1990